NasdaqGM - Delayed Quote USD
Chimerix, Inc. (CMRX)
8.54
0.00
(0.00%)
At close: April 17 at 4:00:02 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALRUTZ MICHAEL ALBERT General Counsel | Sale | Feb 13, 2025 | 213,596 |
ANDRIOLE MICHAEL T. Chief Executive Officer | Sale | Feb 13, 2025 | 609,603 |
DEMSKI MARTHA J. Director | Purchase | May 10, 2023 | -- |
JAKEMAN DAVID A Officer | Sale | Feb 13, 2025 | 148,987 |
LASPALUTO MICHELLE Chief Financial Officer | Sale | Feb 13, 2025 | 172,977 |
MELEMED ALLEN S Officer | Sale | Feb 13, 2025 | 152,875 |
MEYER ROBERT JAMES M.D. Director | Purchase | May 8, 2023 | 35,150 |
MIDDLETON FRED A Director | Stock Gift | Oct 28, 2024 | -- |
RIGA THOMAS J. Chief Operating Officer | Stock Award(Grant) | Jan 7, 2025 | 57,501 |
SHERMAN MICHAEL A Chief Executive Officer | Purchase | May 12, 2023 | -- |
Related Tickers
JAZZ Jazz Pharmaceuticals plc
103.38
+3.03%
J7Z.F Jazz Pharmaceuticals plc
91.48
+1.58%
KZIA Kazia Therapeutics Limited
3.4400
+12.79%
AVTE Aerovate Therapeutics, Inc.
2.7600
-0.36%
CTMX CytomX Therapeutics, Inc.
0.7361
-1.84%
FBRX Forte Biosciences, Inc.
6.85
-2.28%
SLNO Soleno Therapeutics, Inc.
71.40
+3.58%
PSTV Plus Therapeutics, Inc.
0.7870
+22.78%
SCPX Scorpius Holdings, Inc.
0.0680
-48.48%
GLTO Galecto, Inc.
2.6800
+10.74%